Minerva Neurosciences(NERV)
BURLINGTON, MABiotechnology
Focus: Minerva Neurosciences is a public biotech company focused on CNS treatments, particularly schizophrenia and depression. The company operates at a modest scale with 16 active job openings and a lean cash position.
Profile data last refreshed 14h ago · AI intelligence enriched 1w ago
Funding Stage
PUBLIC
Open Jobs
17+9 this month
Growing — net +9 jobs in 30d
10 jobs added vs 1 removed. Steady team buildout.
Should You Work at Minerva Neurosciences?
AI assessmentBest suited for early-career R&D professionals willing to accept pre-revenue risk for focused CNS exposure and potential Phase 3 upside; not recommended for those seeking established infrastructure or commercial-stage stability.
Why Work Here
- Access to Phase 3 assets in high-need CNS indications (schizophrenia negative symptoms, MDD) with near-term catalyst potential
Data completeness
3/9 — Basic
Company HealthStrong
Pipeline
Mid-stage
2 Phase 3+
LOE Risk
Protected
No near-term cliffs
Hiring
Stable
Revenue
$0K
Pipeline & Clinical Trials
MIN-101
SchizophreniaClinical Trials (1)
NCT02232529Pharmacokinetic Study of MIN-101 in Healthy Subjects
Phase 1Help build intelligence for Minerva Neurosciences
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
Data Sources
- Drug label: DailyMed / FDA
- Clinical trials: ClinicalTrials.gov
- Patent data: FDA Orange Book
- Spending data: CMS Medicare
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.